Cancer Antigen 15-3

<strong>Cancer Antigen 15-3</strong>_x000D_ <strong>Catalog number:</strong> B2012262_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 kU_x000D_ <strong>Molecular Weight or Concentration:</strong> 5,000 IU/mL_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> CA 15-3, Tumor Marker 15-3, Mucin-1, MUC-1, Breast carcinoma-associated antigen DF3, Breast Tumor Antigen_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Goodwin PJ, Dowling RJO, Ennis M, Chen BE, Parulekar WR, Shepherd LE, Gelmon KA, Whelan TJ, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Rastogi P, Rabaglio-Poretti M, Lemieux J, Thompson AM, Rea DW, Stambolic V. Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo JNCI Cancer Spectr. 2021 Jul 28;5(5):pkab066._x000D_ 2: Li X, Dai D, Chen B, Tang H, Xie X, Wei W. Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients Dis Markers. 2018 May 2;2018:9863092._x000D_ 3: Duffy MJ, Evoy D, McDermott EW. CA 15-3: uses and limitation as a biomarker for breast cancer Clin Chim Acta. 2010 Dec 14;411(23-24):1869-74._x000D_ 4: Elakkiya V, Menon MP, Nataraj D, Biji P, Selvakumar R. Optical detection of CA 15.3 breast cancer antigen using CdS quantum dot IET Nanobiotechnol. 2017 Apr;11(3):268-276._x000D_ 5: Hing JX, Mok CW, Tan PT, Sudhakar SS, Seah CM, Lee WP, Tan SM. Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance Breast. 2020 Aug;52:95-101._x000D_ 6: Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression Trends Mol Med. 2014 Jun;20(6):332-42._x000D_ 7: Baselice S, Castaldo R, Giannatiempo R, Casaretta G, Franzese M, Salvatore M, Mirabelli P. Impact of Breast Tumor Onset on Blood Count, Carcinoembryonic Antigen, Cancer Antigen 15_3 and Lymphoid Subpopulations Supported by Automatic Classification Approach: A Pilot Study Cancer Control. 2021 Jan-Dec;28:10732748211048612._x000D_ 8: Haidar S, Bhanushali PB, Shukla KK, Modi D, Puri CP, Badgujar SB, Chugh M. Simplified approach for in-vitro production and purification of cell derived Cancer Antigen 15_3 Int J Biol Macromol. 2018 Feb;107(Pt B):1456-1462._x000D_ 9: Terävä J, Tiainen L, Lamminmäki U, Kellokumpu-Lehtinen PL, Pettersson K, Gidwani K. Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma PLoS One. 2019 Jul 25;14(7):e0219480._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34207342">10: Chen W, Zhang Z, Zhang S, Zhu P, Ko JK, Yung KK. MUC1: Structure, Function, and Clinic Application in Epithelial Cancers Int J Mol Sci. 2021 Jun 18;22(12):6567. </a>_x000D_ _x000D_ <strong>Products Related to Cancer Antigen 15-3 can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>